Clavis Pharma ASA : Clavis Pharma ASA : Minutes from Extraordinary General Meeting

  Clavis Pharma ASA : Clavis Pharma ASA : Minutes from Extraordinary General                                    Meeting  Oslo, Norway, May 3, 2013  Clavis Pharma ASA (OSE: CLAVIS), an Extraordinary General Meeting of Clavis Pharma ASA was held on 2 May 2013 in Parkveien 53B, Oslo. Please find the minutes of the Extraordinary General Meeting attached.  The Extraordinary General Meeting elected Martin Nes and Øystein Stray Spetalen as new directors.  The Board of Directors of Clavis Pharma ASA consists of the following board members:  · Anders P. Wiklund (chairman) · Annette Clancy · Martin Nes · Øystein Stray Spetalen · Hilde H. Steineger  Contacts:  Gunnar Manum, CFO Office : +47 24 11 09 71 Mobile : +47 95 17 91 90  E-mail :gunnar.manum@clavispharma.co  This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Minutes from Extraordinary General Meeting  ------------------------------------------------------------------------------  This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.  The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.  Source: Clavis Pharma ASA via Thomson Reuters ONE HUG#1698968